Cardiovascular Systems, Inc.
CSII
CSII was delisted on the 27th of April, 2023.
158 hedge funds and large institutions have $533M invested in Cardiovascular Systems, Inc. in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 53 increasing their positions, 59 reducing their positions, and 29 closing their positions.
9% less funds holding
Funds holding: 173 → 158 (-15)
10% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 59
25% less call options, than puts
Call options by funds: $114K | Put options by funds: $152K
36% less capital invested
Capital invested by funds: $834M → $533M (-$301M)
38% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$16.3M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$12.3M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$8.02M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.8M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$4.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$17.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9.95M |
| 3 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$9.22M |
| 4 |
Millennium Management
New York
|
-$5.42M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$5.15M |
CSII Hedge Fund Activity: Q2 2022 in Review
158 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2022, worth a combined $533M — down 36% from $834M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of CSII and 18 opened new positions — a net loss of 11 holders — while 59 trimmed existing stakes and 53 added.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $16.3M. The largest seller was Champlain Investment Partners, cutting an estimated $17.8M.
- 158 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2022, down from 173 in Q1 2022.
- Funds reported $533M of Cardiovascular Systems, Inc. stock for Q2 2022, down 36% quarter-over-quarter.
- 18 funds opened new Cardiovascular Systems, Inc. positions in Q2 2022 and 29 closed out, a net change of -11 holders.
- The largest Cardiovascular Systems, Inc. buyer in Q2 2022 was Camber Capital Management, an estimated $16.3M added.
- The largest Cardiovascular Systems, Inc. seller in Q2 2022 was Champlain Investment Partners, an estimated $17.8M sold.
Based on aggregated 13F filings for Q2 2022.